Medinol Ltd.

15 clinical trials · Sponsor

Record	Firm	Date
IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System (NCT06071702)	Medinol Ltd.	2025-08-07
First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease (NCT06410313)	Medinol Ltd.	2024-08-15
IonMAN Trial- First in Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System (NCT05364697)	Medinol Ltd.	2022-08-30
BIONICS Small Vessels Trial EluNIR Ridaforolimus Eluting Coronary Stent System (EluNIR) in Coronary Stenosis Trial (NCT04761939)	Medinol Ltd.	2020-12-31
ChampioNIR® SFA Stent EFS Study (NCT03775226)	Medinol Ltd.	2019-10-27
EluNIR Ridaforolimus Eluting Coronary Stent System in Patients at High Bleeding Risk (HBR)- EluNIR HBR Study (NCT03877848)	Medinol Ltd.	2019-05-06

Every clearance here is in the API, with alerts when new ones post.